Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount the results of clinical studies of investigational treatments for chronic hepatitis B
- Describe the resistance profiles of emerging agents for the treatment of chronic viral hepatitis B
- Identify current hepatitis B virus management strategies that may change as a result of current drugs in development
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.